Viewing Study NCT07036861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:58 AM
Ignite Modification Date: 2026-01-03 @ 7:13 PM
Study NCT ID: NCT07036861
Status: COMPLETED
Last Update Posted: 2025-06-25
First Post: 2025-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension
Sponsor: Berlin-Chemie AG Menarini Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Male and Female Subjects View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ibuprofen oral suspension View
None Nurofen oral suspension View
None Bioequivalence study View